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N-methyl-D-aspartate receptors (NMDARs) respond to glutamate to allow the influx of
calcium ions and the signaling to the mitogen-activated protein kinase (MAPK) cascade.
Both MAPK- and Ca2+-mediated events are important for both neurotransmission and
neural cell function and fate. Using a heterologous expression system, we demonstrate
that NMDAR may interact with the EF-hand calcium-binding proteins calmodulin,
calneuron-1, and NCS1 but not with caldendrin. NMDARs were present in primary
cultures of both neurons and microglia from cortex and hippocampus. Calmodulin in
microglia, and calmodulin and NCS1 in neurons, are necessary for NMDA-induced
MAP kinase pathway activation. Remarkably, signaling to the MAP kinase pathway
was blunted in primary cultures of cortical and hippocampal neurons and microglia
from wild-type animals by proteins involved in neurodegenerative diseases: α-synuclein,
Tau, and p-Tau. A similar blockade by pathogenic proteins was found using samples
from the APPSw,Ind transgenic Alzheimer’s disease model. Interestingly, a very marked
increase in NMDAR–NCS1 complexes was identified in neurons and a marked increase
of both NMDAR–NCS1 and NMDAR–CaM complexes was identified in microglia from
the transgenic mice. The results show that α-synuclein, Tau, and p-Tau disrupt the
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signaling of NMDAR to the MAPK pathway and that calcium sensors are important
for NMDAR function both in neurons and microglia. Finally, it should be noted that the
expression of receptor–calcium sensor complexes, specially those involving NCS1, is
altered in neural cells from APPSw,Ind mouse embryos/pups.
Keywords: Alzheimer’s disease, calmodulin, calneuron-1, caldendrin, NCS1, extracellular signal-regulated
kinase, glutamate receptor, proximity ligation assay
INTRODUCTION
As longevity increases, neurodegenerative diseases such as
Alzheimer’s (AD) and Parkinson’s (PD) diseases become a
challenge for health and social security systems. In consequence,
there is an urgent need for interventions that either prevent
neurodegeneration or delay disease progression. Whereas PD
management includes successful therapeutic strategies for
symptom management, they do not stop neurodegeneration.
The situation in the case of AD is worse; the current anti-AD
drugs, acetylcholinesterase inhibitors, and N-methyl-D-aspartate
receptor (NMDAR) modulators are of little anti-symptomatic
efficacy and do not prevent disease progression (Gauthier et al.,
2016; Szeto and Lewis, 2016).
The NMDAR is one of the most important mediators of
excitatory neurotransmission in the brain. It is a tetrameric
protein complex formed by two GluN1 and a combination of
one or two GluN2A or GluN2B subunits. Receptor subunit
expression varies in different brain regions and they convey
slightly different neural responses. Interestingly, cortical and
hippocampal receptors contain mainly GluN2A and GluN2B
subunits (Watanabe et al., 1993; Monyer et al., 1994; Laurie
et al., 1997), being those subunits associated to learning and
memory (Woodhall et al., 2001; Bidoret et al., 2009). A decrease in
NMDAR expression and a variation in subunit composition has
been reported in senescence and in AD animal models (Ułas and
Cotman, 1997; Wakabayashi et al., 1999; Mishizen-Eberz et al.,
2004).
Irrespective of the fact that the NMDAR is a target of current
anti-AD medications (memantine), extrasynaptically located
NMDA receptors have a relevant role in neurodegeneration.
Activation of extrasynaptic receptors may not only regulate
expression of Tau (Paterlini et al., 1998) but they also induce
transcriptional inactivation of CREB (Rönicke et al., 2011;
Grochowska et al., 2017) and also contribute to early synaptic
dysfunction. Thus, NMDAR might be relevant targets to prevent
early synaptic dysfunction and potentially delay neuronal cell
death.
Neural cells express calmodulin, which is ubiquitously
expressed, and some other specific calcium-binding proteins
that, upon Ca2+ binding, participate in events related to
neurotransmission and plasticity. One of them, frequenin/NCS1
was first identified in the nervous system of Drosophila (see
Dason et al., 2012 for review) and later found to be a relevant
calcium sensor in the central nervous system of mammals. NCS1
like calneuron-1 and caldendrin, contains EF hand domains that
participate in Ca2+ binding and mediate the conformational
changes that unfolds a myriad of events affecting signaling
pathways and impacting on gene transcription (McCue et al.,
2010; Burgoyne and Haynes, 2012). Affinity for Ca2+ is variable
and, for instance, calcium binds with less affinity to NCS1 than
to calneuron-1 (Mikhaylova et al., 2006, 2009). Despite Ca2+
is the ion transported across NMDAR (see Pankratov and Lalo,
2014; Paoletti et al., 2013 for review), the modulatory role of EF-
hand calcium-binding proteins in NMDA receptor function is
poorly understood. In this study, we wanted to assess whether
NMDAR may directly interact with calcium sensors in neural
cells and whether this might affect the coupling of the NMDAR
to downstream effectors.
N-methyl-D-aspartate receptor-mediated calcium influx
is upstream of several intracellular signaling cascades.
Interestingly, NMDARs are also expressed in glial cells where
their physiological role is not yet fully elucidated. The first aim
of this paper was to look for potential interactions between
NMDA receptors and calcium-binding proteins. We identified in
both neurons and microglia that calcium-binding proteins may
interact with NMDAR and we determined how these proteins
affect NMDAR-mediated MAP kinase activation. The second
aim was to investigate how such NMDAR signaling may be
affected by α-synuclein and Tau proteins. Finally, we analyzed
whether the results obtained in non-transgenic mice were similar
or not to those obtained using cortical and hippocampal neurons
and microglia from the APPSw,Ind transgenic AD mouse model.
RESULTS
NMDAR May Interact With Calneuron-1,
Calmodulin, and NCS1
The activation of ionotropic NMDAR results in Ca2+-influx
and the kinetics as well as amplitude of these synaptic signals
are decoded by calcium sensors (Raghuram et al., 2012).
Previous data suggest an interaction of NMDAR and CaM
(Ehlers et al., 1996) that was here confirmed by means
of bioluminescence resonance energy transfer (BRET) assays
in a heterologous expression system where GluN1 fused to
Rluc and the GluN2B were co-expressed for proper NMDA
receptor reconstitution and functional activity (Figure 1). First,
immunocytofluorescence assays performed in HEK-293T cells
co-expressing NMDAR and CaM showed a prominent degree of
co-localization. Subsequently, a saturation curve demonstrating
a specific interaction was obtained in BRET assays using
GluN1Rluc and CaMYFP in the presence (BRETmax 47± 2 mBU
and BRET50 31 ± 6; Figure 1) or absence (BRETmax 191 ± 8
mBU and BRET50 3.5 ± 1; Supplementary Figure S1A) of
GluN2. We then tested the interaction of other neuron-specific
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FIGURE 1 | The NMDAR receptor interacts with calmodulin, calneuron-1, and NCS1. (A) Confocal microscopy images of HEK-293T cells transfected with cDNAs
for GluN1Rluc (0.5 µg), GluN2B (0.3 µg), and CaMYFP (0.5 µg), calneuron-1-YFP (0.75 µg), NCS1YFP (0.5 µg), or caldendrinYFP (0.75 µg). Calcium sensors fused
to YFP were identified by their own fluorescence (green) and GluN1Rluc by immunoreactivity (red); co-localization is shown in yellow; scale bars: 10 µm. (B–E) BRET
[BRET1 except BRET2 in (D)] saturation experiments in HEK-293T cells transfected with cDNAs for GluN1RLuc (0.3 µg), GluN2B (0.3 µg), and increasing amounts
of cDNA for CaMYFP (0.05–0.4 µg) (B), calneuron-1YFP (0.05–1 µg) (C), NCS1-GFP2 (0.05–0.6 µg) (D), or caldendrinYFP (0.05–1 µg) (E). Values are the
mean ± SEM (n = 8).
calcium sensors by immunocytofluorescence and BRET assays.
Co-localization was proven for the calcium-binding proteins
NCS1 and calneuron-1 but not for caldendrin (Figure 1A).
BRET results confirmed that NMDAR may interact with NCS1
and calneuron-1 but not with caldendrin. In fact, a saturation
BRET curve was obtained using the GluN1Rluc and calneuron-
1YFP in the presence (BRETmax 34 ± 1 mBU and BRET50
1.0 ± 0.3; Figure 1C) or absence (BRETmax 43 ± 4 mBU
and BRET50 10 ± 3; Supplementary Figure S1B) of GluN2.
It should be noted that BRET with GluN1Rluc and NCS1-
YFP in the presence of GluN2 lead to an unspecific signal.
However, in the absence of GluN2, the BRET of the GluN1Rluc
and NCS1-YFP pair was saturable (BRETmax 73 ± 7 mBU and
BRET50 30 ± 7; Supplementary Figure S1C). We repeated
the energy transfer experiment using BRET2 (instead of regular
BRET or BRET1) and the GluN1Rluc and NCS1-GFP2 pair
(in the presence of GluN2). BRET2 was saturable (BRETmax
67 ± 3 mBU and BRET50 35 ± 7; Figure 1D). This result
can be explained due to a better orientation between donor
and acceptor when NCS1-GFP2 was used. Finally, in HEK-
293T cells expressing GluN1Rluc and caldendrinYFP, the linear
unspecific signal observed in the presence (Figure 1E) and
absence of GluN2 (Supplementary Figure S1D) indicates a lack
of interaction between this calcium sensor and the NMDAR.
In conclusion, these data demonstrate that GluN1/N2-NMDAR
may interact with calneuron-1, CaM, and NCS1 but not with
caldendrin.
NMDAR-Mediated ERK1/2
Phosphorylation Is Regulated by CaM,
Calneuron-1, and NCS1
N-methyl-D-aspartate receptor activation leads to the activation
of the mitogen-activated protein kinase (MAPK) pathway
(Wang et al., 2007). In preliminary experiments, we confirmed
that application of NMDA induces the phosphorylation of
ERK1/2 and increases the level of intracellular calcium while it
did not modify the levels of cAMP (data not shown), which were
determined as a control because the NMDAR is not coupled to
heterotrimeric G proteins linked to adenylate cyclase. We then
tested whether co-expression of NMDAR and calcium sensors
affected calcium mobilization. In transiently transfected HEK-
293T cells co-expressing the receptor and the calcium-binding
proteins, NMDA treatment led to a dose–response increase
in the calcium signal (Figure 2). NMDA-induced increases in
Ca2+ levels were obtained when co-transfecting the receptor and
CaM, calneuron-1, or NCS1. Whereas the maximal effect was
similar when the three sensors were heterologously expressed
and when CaM was heterologously expressed, the maximal
effect was lower when calneuron-1 or NCS1 were individually
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FIGURE 2 | NMDAR -mediated signaling in the presence of calcium sensors. (A–D) HEK-293T cells were transfected with the cDNAs for an engineered calcium
sensor, 6GCaMP (0.5 µg), GluN1 (0.4 µg), GluN2B (0.25 µg), and calneuron-1 (0.5 µg) (B), CaM (0.3 µg) (C), NCS1 (0.3 µg) (D), or all three (A). Cells were treated
with different concentrations of NMDA [500 nM (purple), 1 µM (pink), 15 µM (green), and 50 µM (red)] or pretreated with the NMDAR specific antagonist MK-801
(10 µM) followed by 15 µM NMDA stimulation (blue). Representative traces of intracellular Ca2+ responses over time are shown from five independent experiments.
(E,F) HEK-293T cells were transfected with cDNAs for GluN1 (0.4 µg), GluN2B (0.25 µg), and calneuron-1 (0.5 µg) (F), CaM (0.3 µg) (G), NCS1 (0.3 µg) (H), or all
three (E). Cells were treated with different concentrations of NMDA (from 500 nM to 100 µM) or pretreated with the NMDAR specific antagonist MK-801 (10 µM)
followed by treatment with NMDA (15 or 50 µM) and ERK1/2 phosphorylation levels were measured. Values are the mean ± SEM (n = 7). Significant differences over
basal condition were calculated by one-way ANOVA and Bonferroni post hoc test (∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.005).
expressed; interestingly, the peak signal when NCS1 was
expressed occurred at lower NMDA concentrations (Figure 2). In
all cases, pretreatment with the specific NMDAR antagonist MK-
801 (10 µM) followed by 15 µM NMDA treatment, completely
abolished NMDA-induced calcium signals (Figure 2).
We subsequently analyzed how NMDA treatment of cells
leads to ERK1/2 phosphorylation in cell expressing NMDAR and
the different calcium sensor proteins. HEK-293T cells expressing
GluN1 and GluN2 subunits, and CaM, calneuron-1, and NCS1
responded to NMDA treatment and the effect was blocked by the
pretreatment with MK-801 (10 µM) (Figure 2E). Again, it was
observed that exogenously expressed CaM produced the highest
levels of NMDA-induced ERK1/2 phosphorylation. Responses
were evident but smaller in cells expressing calneuron-1 or NCS1
(Figure 2).
Interaction of NMDAR and Calcium
Sensors in Cultured Neurons and
Microglia
To demonstrate the role of calcium sensor modulation of
NMDAR signaling toward the MAP kinase pathway, we moved to
primary cultures from mouse brain. When cortical neurons kept
for 12 days in culture were treated with increasing concentrations
of NMDA (1.5–50 µM), ERK1/2 phosphorylation was obtained
(Figure 3A). It should be noted that no segregation of synaptic
and extrasynaptic NMDAR was yet evident in these cultures.
We subsequently used a RNA-based silencing approach to assess
the role of each calcium sensor on the NMDAR-mediated
responses. When calneuron-1 expression was reduced, the signal
obtained was slightly reduced and/or similar depending on the
NMDA concentration (Figure 3A). By contrast, the effect of
NMDA was totally blocked when CaM or NCS1 expressions were
silenced (Figure 3A). Equivalent results were obtained in neurons
from mouse hippocampus (Figure 3B). These results in cortical
and hippocampal neurons indicate that CaM or NCS1 allows
signaling from NMDAR activation to ERK1/2 phosphorylation.
Similar experiments were performed in primary cultures of
microglia from cortex or hippocampus. Rather surprisingly, it
was observed that NMDAR activation in microglia leads to
significant ERK1/2 phosphorylation. In cortical and hippocampal
microglia, the NMDAR signal was not blunted when siRNAs
against calneuron-1 or NCS1 were used but only when
CaM expression was silenced (Figures 3C,D). NCS1 is barely
expressed in microglia while calneuron-1 (Hradsky et al., 2015)
is not expressed. To obtain more information concerning
the occurrence of interactions between NMDAR and calcium
sensors, in situ proximity ligation assays (PLAs) were performed.
The technique is suitable to detect complexes of two endogenous
proteins, either in tissue slices or in primary cell cultures.
PLA showed that cortical and hippocampal neurons display
complexes of NMDAR with both CaM and NCS1 sensors
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FIGURE 3 | NMDAR-mediated signaling in primary cultures of neurons and microglia from cortex and hippocampus. (A–D) MAPK phosphorylation levels were
analyzed after stimulating with NMDA (at the indicated concentrations) primary cultures of cortical (A), or hippocampal neurons (B), or of cortex (C) or hippocampal
microglia (D). Experiments were performed in cells transfected or not (black bars) with siRNA to silence calneuron-1 (red bars), CaM (green bars), or NCS1 (blue
bars) expression. Different concentrations of NMDA (from 50 to 1.5 µM) were used to activate the receptor and the NMDAR antagonist, MK-801 (10 µM), was used
for specificity checking. Labels in X axis are equal in bar graphs of panels (A–D). Values are the mean ± SEM (n = 12). Significant differences over basal condition
were calculated by one-way ANOVA and Bonferroni post hoc test (∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.005). (E) Proximity ligation assays (PLAs) were performed in
primary cultures of mice cortex or hippocampus and primary antibodies specific for NMDAR and for calneuron-1, CaM, or NCS1. Confocal microscopy images are
shown (superimposed sections) in which heteromers appear as red clusters (in neurons or microglia). Scale bars = 10 µm (neurons) and 20 µm (microglia). In all
cases, cell nuclei were stained with Hoechst (blue).
(Figure 3E). By contrast, in microglial cultures, NMDAR only
interacted with CaM (Figure 3E). The PLA specificity was
demonstrated by lack of signal when a primary antibody was
omitted (Supplementary Figure S2). These results fit with the
results of ERKs phosphorylation, namely, NMDAR interact with
and its signaling to MAPK depends on CaM and NCS1 in cortical
and hippocampal neurons, whereas the signaling via NMDAR in
cortical and hippocampal microglia only depends on CaM.
α-Synuclein Fibrils Block NMDA-Induced
MAPK Activation
It is well established that α-synuclein is a presynaptic protein
that contributes to PD pathogenesis. First, to test the potential
effect of recombinant human α-synuclein on NMDAR-
mediated activation of the MAPK pathway, primary cultures of
hippocampal or cortical neurons were treated with increasing
concentrations of α-synuclein fibrils obtained by sonication
(1–100 µg/L) (Supplementary Figures S3D,H). Thus, in
subsequent experiments, the concentration of α-synuclein
used was 10 µg/L. In acute treatment, the protein was
added 2 h prior treatment with NMDA, whereas in chronic
treatment, α-synuclein was preincubated for 7 days. ERK1/2
phosphorylation assays were performed in primary cultures
of neurons or microglia from cortex or hippocampus, treated
or not with siRNAs able to knockdown calneuron-1, CaM,
or NCS1 expression. First of all, we observed that in all
neurons and glia (hippocampal and cortical) cells, the acute
treatment completely abolished the effect of NMDAR on ERK1/2
phosphorylation (Figure 4). When cultures were treated with
siRNA for calneuron-1 (red), CaM (green), or NCS1 (blue),
the effect was similar. Accordingly, when CaM and NCS1 in
neurons or CaM in microglia are silenced thus blocking the
NMDA response, α-synuclein could not display any effect.
When similar experiments were undertaken under a chronic
condition (10 µg/L α-synuclein for 7 days), the results were
similar (Supplementary Figure S4). Adenosine deaminase
(ADA), which binds to various cell surface receptors that are
widely expressed in CNS and peripheral cells [CD26/DPPIV
and adenosine receptors (Franco et al., 1988; Corset et al., 2000;
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FIGURE 4 | Acute treatment with Tau, p-Tau, or α-synuclein inhibits NMDAR-mediated signaling in primary cultures. (A–D) MAPK phosphorylation levels were
analyzed after stimulating primary cultures of cortical (A), or hippocampal neurons (B), or of cortical (C), or hippocampal microglia (D). Labels in X axis are equal in
all bar graphs. Experiments were performed in cells transfected or not (black bars) with siRNA to silence calneuron-1 (red bars), CaM (green bars), or NCS1 (blue
bars) expression. Assays were performed in cells treated with α-synuclein, Tau, or p-Tau for 2 h prior to 15 µM NMDA addition. Values are the mean ± SEM (n = 10).
Significant differences over non-treated cells (∗∗p < 0.01 and ∗∗∗p < 0.005) or over NMDA treatment (&p < 0.05 and &&p < 0.01) were calculated by one-way
ANOVA and Bonferroni post hoc test.
Ruiz et al., 2000; Herrera et al., 2001; Pacheco et al., 2005)]
served as a negative control; ADA did not affect the NMDAR-
mediated ERK1/2 phosphorylation (Supplementary Figure S3).
In summary, acute or chronic α-synuclein fibril treatment of
primary cultures blocks engagement of MAP kinase by NMDA.
Tau and p-Tau Block NMDA-Induced
MAPK Activation
Tau is a microtubule-associated protein that interacts with
tubulin. Normal adult human brain Tau contains 2–3 moles
phosphate/mole of Tau protein (Iqbal et al., 2010) while AD
patients contain hyperphosphorylated Tau, which is an aberrant
form leading to neurofibrillary tangles. Interestingly, trans-
synaptic spreading of pathological Tau among interconnected
neural circuits have been postulated to be critical in tauopathies
and linked to progression of AD pathology (Medina and Avila,
2014; Goedert et al., 2017; Mudher et al., 2017). To elucidate
the relevance of Tau and p-Tau effects over NMDAR function,
experiments similar to those above described for α-synuclein
were performed in primary cultures of cells pre-treated with
either Tau of p-Tau. First, neuronal primary cultures were
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treated with increasing concentrations of Tau (0.05–5 µg/L) and
p-Tau (0.05–5 µg/L) (Supplementary Figures S3B,C,F,G). In
subsequent experiments, the concentration of Tau or p-Tau was
0.5 µg/L. In acute treatment, each of these proteins was added
2 h prior treatment with NMDA, whereas in chronic treatments,
cells were incubated for 7 days with Tau or p-Tau. The results
showed that both p-Tau and Tau inhibited NMDAR function in
acute (Figure 4) and also in chronic conditions (Supplementary
Figure S4). In summary, Tau and p-Tau markedly affected
receptor signaling to MAP kinases in both neurons and microglia
from cortex or hippocampus. ERK1/2 phosphorylation assays
were performed in primary cultures of neurons or microglia
from cortex or hippocampus, treated or not with siRNAs able to
knockdown calneuron-1, CaM, or NCS1 expression. When CaM
and NCS1 in neurons or CaM in microglia were silenced thus
blocking the NMDA response, Tau or p-Tau could not display
any effect.
NMDA Receptor/Calcium Sensor
Interactions in Neurons From APPSw,Ind
Transgenic Model
N-methyl-D-aspartate receptor function is altered in neurons
affected by AD. Accordingly, we isolated primary cultures of
neurons from transgenic APPSw,Ind and control mice to check
for occurrence of complexes (by PLA) and for the integrity of
the link of NMDAR to the MAPK pathway. First of all, NMDA
potentiated ERK1/2 phosphorylation in APPSw,Ind transgenic
mice (white bars) with respect to phosphorylation in control
animals (black bars) (Figure 5A). Moreover, when neurons from
APPSw,Ind transgenic mice were transfected with siRNA to silence
CaM or NCS-1 expression, the MAPK phosphorylation was
completely abolished, indicating that CaM and NCS-1 proteins
are (as in control animals) required for NMDAR function. By
contrast, silencing of calneuron-1 had no effect over NMDA
actions. PLAs developed to assess the formation of NMDAR–
calcium sensor complexes in primary cultures showed that in
control animals (black bars) 77% of neurons express NMDAR–
CaM complexes while only 21 and 14% of neurons showed,
respectively, NMDAR–NCS1 and NMDAR–calneuron-1 clusters
(Figure 5C,D). Looking for differences in transgenic animals, the
most striking result was the increase in the percentage of cells
expressing NCS1–NMDAR complexes (from 21 to 68%) plus the
significant increase in the number of clusters per cell (from circa 2
to 5.5; Figure 5). These results suggest in the AD mice model that
the link NMDAR–MAPK in neurons requires CaM and NCS1
calcium sensor expression, with a more relevant role of NCS1 as
the amount of NMDAR–NCS1 heteromers is altered if compared
with control animals.
Finally, NMDAR function was assayed in neuronal primary
cultures of APPSw,Ind transgenic mice treated with Tau, p-Tau,
or α-synuclein for 2 h prior to 15 µM NMDA addition. The
results show that not only Tau and p-Tau proteins but also
α-synuclein were able to significantly decrease NMDA-induced
MAPK activation (Figure 5). These results indicate that neither
endogenous Tau nor p-Tau can revert the higher sensitivity of
NMDA action in neurons of transgenic mice.
NMDA Receptor/Calcium Sensor
Interactions in Microglia From APPSw,Ind
Transgenic Model
To analyze the status of the NMDAR-MAP kinase link in an
AD model, primary cultures of microglia from non-transgenic
(control) or APPSw,Ind transgenic mice were cultured and
treated with NMDA (15 µM). Interestingly, the results of
ERK1/2 phosphorylation indicated that NMDAR function was
potentiated in microglia from the APPSw,Ind transgenic mice
(white bars in Figure 6). When cultures were transfected
with siRNA to silence calneuron-1 expression, a similar
result was obtained thus suggesting that calneuron-1 is not
involved in the NMDA effect on MAPK activation (Figure 6A,
microglia from control in black, from transgenic in white). By
contrast, when cultures were transfected with siRNA to silence
CaM expression, it was observed that the NMDAR signaling
completely disappeared in microglia from both control and
APPSw,Ind mice, indicating that CaM interaction with NMDAR
is required for receptor-mediated engagement of the MAPK
pathway. In fact, these results are in agreement with the data
shown in Figure 3. Finally, when microglia primary cultures
of APPSw,Ind transgenic mice and control animals were treated
with siRNA to decrease NCS1 expression, the abolishment
of NMDA effect was only observed in the APPSw,Ind-derived
cells (Figure 6A). The results indicate that the NCS1–NMDAR
interaction is relevant for receptor function in the microglia of
the AD mouse model.
Finally, formation of complexes of NMDA receptors and
calcium-binding proteins was detected by PLA in primary
cultures of microglia from APPSw,Ind and control mice.
Interestingly, we observed that in control animals (black bars),
only CaM formed heteromeric complexes with the NMDA
receptor (35% of cells showing around three red dots/ cell
containing dots) with negligible values for interactions with
calneuron-1 or NCS1 (respectively, 1.85 and 4.8% of cells
expressing red dots). When APPSw,Ind microglia was analyzed,
the number of complexes between NMDAR and CaM was
markedly higher (65% of cells showing around 6 red dots/
cell containing dots), whereas the degree of interaction with
calneuron-1 was negligible (1.9% of cells containing red
dots). It should be also noted that complexes of NCS1 and
NMDAR were also noticeable in the APPSw,Ind microglia
thus indicating a NMDAR-NCS1 interaction in microglia that
deserves attention when addressing AD pathophysiology. While
the NCS1 expression in microglia from wild-type animals
is reportedly low (Averill et al., 2004; Hradsky et al., 2015;
Nakamura et al., 2017), the substantial increase in NMDAR-
NCS1 complexes shown in Figures 6B,C, suggests that expression
of NCS1 in microglia from the APPSw,Ind mice is significant.
DISCUSSION
The arguably two most relevant neuronal second messengers
whose intracellular concentration changes upon cell surface
receptor activation are cAMP and Ca2+. In our efforts to
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FIGURE 5 | NMDAR-mediated signaling in primary neurons from APPSw,Ind mice. (A,B) Primary cultures from non-transgenic control (black bars) and APPSw,Ind
(white bars) embryos were isolated and transfected or not with siRNA for silencing calneuron-1, CaM, or NCS1. In (A), neurons were treated with 15 µM NMDA, while
in (B), neurons were previously treated with α-synuclein, Tau, or p-Tau for 2 h prior to 15 µM NMDA addition; finally, ERK1/2 phosphorylation was measured. Values
are the mean ± SEM (n = 6). One-way ANOVA followed by Bonferroni’s multiple comparison post hoc test were used for statistics analysis. ∗p < 0.05, ∗∗p < 0.01,
and ∗∗∗p < 0.001 versus NMDA treatment; comparing only white (non-transgenic data) or only black (transgenic data) bars. (C) PLA performed in primary cultures
from non-transgenic control (black bars) and APPSw,Ind (white bars) embryos, using specific primary antibodies raised against NMDAR and calneuron-1, CaM, or
NCS1. Confocal microscopy images (stacks of four consecutive planes) show heteroreceptor complexes as red clusters surrounding Hoechst-stained nuclei (blue).
Scale bar: 15 µm. The bar graph (D) shows the number of red dots/cell and the number above bars indicate the percentage of cells presenting red dots. Values are
the mean ± SEM (n = 5). One-way ANOVA followed by Bonferroni’s multiple comparison post hoc test was used for statistics analysis (∗∗∗p < 0.001, versus control).
look for cAMP- and calcium-signaling cross-talk, we have
shown direct interactions between calcium sensors and receptors
for neurotransmitters/neuromodulators that are coupled to G
proteins (GPCRs), i.e., metabotropic receptors. Interestingly, the
interaction with calcium sensors in conditions of elevated Ca2+
levels results in marked modulation of the signaling events
mediated by the cell surface GPCRs expressed in neurons (Lian
et al., 2011; Mikhaylova et al., 2011; Navarro et al., 2012a,b, 2014).
In a heterologous expression system, we found that with the
exception of caldendrin, all investigated calcium sensors may
interact with the GluN1 subunit of NMDAR. Caldendrin is
highly abundant in pyramidal neurons (Seidenbecher et al., 1998;
Mikhaylova et al., 2018) and also part of the protein complex
formed by the calcium sensor and an interacting partner, Jacob,
that links NMDAR-mediated signaling to the nucleus (Dieterich
et al., 2008) in a cytocrin fashion (Navarro et al., 2017). Our
data using a heterologous expression system indicate that no
direct interaction occurs with the GluN1 subunit under these
conditions.
The NMDAR is one of the upstream players that impact on
the MAP kinase signaling pathway. The present study suggests
that the coupling of the MAPK pathway to NMDAR activation
depends on the expression of calcium sensors. Interestingly,
CaM is providing the link in primary cultures of cortical and
hippocampal microglia, whereas CaM or NCS1 provide the link
in cortical and hippocampal neurons. Among the few studies
linking calcium sensors to ionotropic related neurophysiological
events, those performed by Jo et al. (2008) in synapses of the
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FIGURE 6 | NMDAR-mediated signaling in primary microglia from APPSw,Ind mice. (A) Primary microglial cultures from non-transgenic control (black bars) and
APPSw,Ind (white bars) mice were isolated and transfected or not with siRNA for silencing calneuron-1, CaM, or NCS1. Microglia were treated with 15 µM NMDA and
MAPK phosphorylation was measured. Values are the mean ± SEM (n = 6). One-way ANOVA followed by Bonferroni’s multiple comparison post hoc test were used
for statistics analysis (∗∗∗p < 0.001 versus control). (B) Primary microglial cultures from non-transgenic control (black bars) and APPSw,Ind (white bars) mice were
assayed for potential interactions between NMDAR and calcium sensors. PLA was performed using primary cultures of microglia and specific primary antibodies
raised against NMDAR and calneuron-1, CaM, or NCS1. Confocal microscopy images (stacks of four consecutive planes) show heteroreceptor complexes as red
clusters surrounding Hoechst-stained nuclei (blue). Scale bar: 10 µm. The bar graph (C) shows the number of red dots/cell and the number above bars indicate the
percentage of cells presenting red dots. Values are the mean ± SEM (n = 6). One-way ANOVA followed by Bonferroni’s multiple comparison post hoc test was used
for statistics analysis (∗∗∗p < 0.001, comparing each condition versus control, i.e., comparing one by one white versus the corresponding black bar).
perirhinal cortex showed that long-term depression mediated by
ionotropic glutamate NMDA receptors involves CaM, whereas
long-term depression mediated by metabotropic G-protein-
coupled glutamate receptors involves NCS1. In primary cultures
of neurons, the link to MAP kinase activation was blocked
by α-synuclein, Tau, and p-Tau, which are relevant players in
the pathophysiology of proteinopathies such as AD and PD.
The effect was similar in neurons and in microglia. Taking
into account the similar blockade (both in acute and chronic
treatments) by the three different proteins, and the fact that the
calcium sensors modulate the coupling of NMDAR to the MAPK
pathway, the blockade may result from direct interaction with
NMDAR or by interference of signaling events downstream of
the receptor.
Microglia, first considered as detrimental when activated due
to brain damage or neurodegeneration, appear now with huge
potential for neuroprotection (Franco and Fernández-Suárez,
2015). In a previous work using the APPSw,Ind transgenic AD
mice, we found that primary cultures of microglia from pup
brain display an activated phenotype (Navarro et al., 2018).
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As young APPSw,Ind animals do not display any cognitive
impairment, such finding could indicate that activated microglia
are neuroprotective in this animal model. Accordingly, we
wanted to assess possible alterations in the functioning of
NMDAR in such cells. On the one hand, NMDAR are coupled
to MAP kinases but with a differential finding respect to that in
cells from control animals. In fact, the NMDA-induced increase
of ERK1/2 phosphorylation was independent of calneuron-1 but
modulated by CaM and NCS1. In parallel assays performed
in cells from control animals, the effect was only inhibited
by silencing CaM in microglia (or by silencing CaM and
NCS-1 in neurons). Further data on assessing the complexes
involving NMDA receptors confirmed a significant increase in
the number of microglial cells expressing NMDAR/CaM and
NMDA/NCS1 complexes and in the number of clusters per cell.
In neurons, the relevant increase in both percentage of expressing
cells and amount of clusters/cell concerned NMDAR/NCS1
complexes.
The results obtained in primary cultures (neurons and
microglia) from transgenic mice show exacerbation of NMDA-
induced MAPK activation. These results combined with
the effect of pathogenic proteins leads to two possibilities,
namely, (i) hyperactivation is independent of the presence of
those (endogenously expressed) proteins or (ii) neural cells
counteract the effect of α-synuclein fibrils, Tau, and p-Tau
by increasing NMDAR signaling function. Accordingly, the
molecular underpinnings and potential differences thereof in
the relationship between NMDAR and calcium-binding proteins
deserves further experimental effort. What it is however relevant
in our findings in the AD model is the increase in the
expression of NMDAR–NCS1 complexes; the consequences of
such significant change (in neurons: > 3-fold in number of cells
expressing complexes and >fourfold the number of complexes




N-methyl-D-aspartate and MK-801 were purchased from Tocris
Bioscience (Bristol, United Kingdom). Recombinant human
α-synuclein was prepared as described (Matsuda et al., 1990) and
Tau and p-Tau proteins were kindly provided by Prof. J. Avila
(CBM, UAM-CSIC, Madrid, Spain). Detailed descriptions of the
elaboration and processing of proteins can be found elsewhere
(Pérez et al., 2002; Tarutani et al., 2016).
Expression Vectors
cDNA for the human version of the GluN1 subunit of
NMDAR lacking the stop codon was obtained by PCR and
subcloned to RLuc-containing vector (pRLuc-N1; PerkinElmer,
Wellesley, MA, United States) using sense and antisense primers
harboring unique restriction sites for HindIII and BamHI; the
generated cDNA encodes a GluN1Rluc fusion protein. cDNA
for the human version of GluN2B subunit of NMDAR was
subcloned in pcDNA3.1. In functional assays, both cDNAs
encoding for GluN1 and GluN2B were cotransfected. CaM
gene sequence from pcDNA3 was subcloned in pEYFP-N1
vector (pEYFP: enhanced yellow variant of GFP; Clontech,
Heidelberg, Germany), as previously described (Navarro et al.,
2009) to generate a plasmid encoding CaM-YFP fusion protein.
cDNA constructs encoding NCS1, calneuron-1, or caldendrin
in pcDNA3 vectors were subcloned in pEYFP-N1 or pGFP2-
N1 vectors as previously described in (Navarro et al., 2012b) to
generate plasmids encoding NCS1YFP, NCS1GFP2, calneuron-
1YFP, and caldendrinYFP fusion proteins. The cDNA for
calneuron-1, caldendrin, and NCS1, cloned into pcDNA3.1, were
amplified (omitting stop codons) using sense and antisense
primers harboring unique HindIII and BamHI sites to clone
the amplified fragments to be in frame in the pEYFP-N1 or
pGFP2-N1 vectors.
APPSw,Ind Transgenic Mice
APPSw,Ind transgenic mice (line J9; C57BL/6 background)
expressing human APP695 harboring the FAD-linked Swedish
(K670N/M671L) and Indiana (V717F) mutations under the
PDGFβ promoter were obtained by crossing APPSw,Ind to non-
transgenic (control) mice (Mucke et al., 2000). Control and
APPSw,Ind embryos (E16.5) were genotyped individually and
used for microglia cultures as described elsewhere (Navarro
et al., 2018). Animal care and experimental procedures were in
accordance with European and Spanish regulations (86/609/CEE;
RD1201/2005). Mice were handled, as per law, by personnel with
the ad hoc certificate (issued by the Generalitat de Catalunya) that
allows animal handling for research purposes.
Cell Culture and Transient Transfection
HEK-293T cells were grown in in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 2 mM L-
glutamine, 100 U/ml penicillin/streptomycin, and 5% (v/v)
heat inactivated fetal bovine serum (FBS) (Invitrogen, Paisley,
Scotland, United Kingdom). Cells were maintained in a
humid atmosphere of 5% CO2 at 37◦C. Cells were transiently
transfected with the polyethylenimine (PEI, Sigma, St. Louis,
MO, United States) method. To prepare mice cortex and
hippocampus primary microglial cultures, brain was removed
from C57/BL6 mice between 2- and 4-days-old. Microglia cells
were isolated as described in (Newell et al., 2015) and plated
at confluence of 40,000 cells/0.32 cm2 and grown in DMEM
medium supplemented with 2 mM L-glutamine, 100 U/ml
penicillin/streptomycin, and 5% (v/v) heat inactivated FBS
(Invitrogen, Paisley, Scotland, United Kingdom) for 12 days.
Neuronal primary cultures were prepared from cortex and
hippocampus of fetuses from C57/BL6 pregnant mice. Neurons
were isolated as described in Hradsky et al. (2013) and plated at
a confluence of 40,000 cells/0.32 cm2. Striatal cells were grown
in neurobasal medium supplemented with 2 mM L-glutamine,
100 U/ml penicillin/streptomycin, and 2% (v/v) B27 supplement
(Gibco) in a 96-well plate for 12 days.
Silencing of constitutively expressed calcium-binding
proteins was performed as described elsewhere (Navarro et al.,
2014). Briefly, cortical or hippocampal cultures (neurons or
microglia) growing in 96-well plates were transfected with
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the Lipofectamine R©2000 (Thermo Fisher) method to silence
the NCS1, CaM, or calneuron-1 expression using pSuper-
NCS-1 vector, pSuper-CaM vector, and calneuron-1 shRNAII
(1xconstruct #2; genecopoeia). Cells were incubated for 6–8 h
with the cDNA and Lipofectamine R© in serum-starved medium.
After 6–8 h, the medium was replaced with a complete culture
medium. Validation was performed by Western blotting and
the reduction in expression from control values (>75% in
neurons;>85% in microglia). Rescuing assays were performed in
primary cultures (already expressing endogenous CaM) by first
silencing CaM using a specific siRNA and further transfection
with a vector containing the CaM sequence. The results related
to the NMDAR–MAPK link disappeared upon silencing but
re-appeared upon “reexpression” of CaM by transfection with
the specific cDNA (Supplementary Figure S5).
Preparation of Human α-Synuclein Fibrils
α-Synuclein fibrils were prepared by shaking purified
recombinant α-synuclein as described (Masuda-Suzukake
et al., 2014; Tarutani et al., 2016). Briefly, purified recombinant
α-synuclein (5 mg/ml) containing 30 mM Tris–HCl (pH 7.5),
10 mM DTT, and 0.1% sodium azide were incubated for 7 days
at 37◦C in a horizontal shaker at 200 rpm, then ultracentrifuged
at 113,000 × g for 20 min at 25◦C. The pellets were washed
with saline and ultracentrifuged as before. The resulting pellets
were collected as α-synuclein fibrils and resuspended in 30 mM
Tris–HCl (pH 7.5). The fibrils were fragmented using a cup horn
sonicator (Sonifier R© SFX, Branson) at 35% power for 180 s (total
240 s, 30 s on, 10 s off) (Tarutani et al., 2016, 2018). Before use
aliquots were left at room temperature and placed in PBS 1× (pH
7.2) to a final concentration of 0.1 µg/µL. These preparations
were subjected to 60 pulses of sonication (runtime 30 s: 0.5 s
on, 0.5 s off in a BBR03031311digital SONIFIER sonicator).
Sonicated fibril preparations were diluted in pre-warmed
medium and immediately added to cells.
Bioluminescence Resonance Energy
Transfer (BRET) Assays
For BRET1, HEK-293T cells were transiently co-transfected with
a constant amount of cDNA encoding for GluN1-RLuc and
GluN2B in pcDNA3.1 and with increasing amounts of cDNA
corresponding to calneuron-1-YFP, caldendrin-YFP, CaM-YFP,
or NCS1-YFP. 48 h after transfection cells were adjusted to
20 µg of protein using a Bradford assay kit (Bio-Rad, Munich,
Germany) using bovine serum albumin for standardization.
To quantify protein-YFP expression, fluorescence was read in
a Mithras LB 940 equipped with a high-energy xenon flash
lamp, using a 30-nm bandwidth excitation filter at 485 nm.
For BRET measurements, readings were collected 30 s after
the addition of 5 µM coelenterazine H (Molecular Probes,
Eugene, OR, United States) using a Mithras LB 940, which
allows the integration of the signals detected in the short-
wavelength filter at 485 nm and the long-wavelength filter at
530 nm. To quantify protein-RLuc expression, luminescence
readings were performed 10 min after 5 µM coelenterazine
H addition using a Mithras LB 940. For BRET2, HEK-293T
cells were transiently co-transfected with a constant amount of
cDNA encoding for GluN1-RLuc and GluN2B in pcDNA3.1
and with increasing amounts of cDNA corresponding to NCS1-
GFP2. 48 h after transfection cells were adjusted to 20 µg
of protein using a Bradford assay kit (Bio-Rad, Munich,
Germany) using bovine serum albumin for standardization.
To quantify protein-GFP2 expression, fluorescence was read
in a Fluostar Optima fluorimeter equipped with a high-
energy xenon flash lamp, using a 10-nm bandwidth excitation
filter at 405 nm. For BRET measurements, readings were
collected 1 min after the addition of 5 µM Deep Blue
C (Molecular Probes, Eugene, OR, United States) using a
Mithras LB 940, which allows the integration of the signals
detected in the short-wavelength filter at 405 nm and the
long-wavelength filter at 510 nm. To quantify protein-RLuc
expression, luminescence readings were performed 10 min after
5 µM coelenterazine H addition using a Mithras LB 940. The
net BRET is defined as [(long-wavelength emission)/(short-
wavelength emission)] − Cf, where Cf corresponds to [(long-
wavelength emission)/(short-wavelength emission)] for the
donor construct expressed alone in the same experiment.
GraphPad Prism software (San Diego, CA, United States) was
used to fit data. BRET is expressed as milli BRET units, mBU
(net BRET × 1,000) (Canals et al., 2003, 2004; Hinz et al.,
2018).
Immunocytofluorescence
HEK-293T cells were transfected with GluN1-RLuc, GluN2B,
and calneuron-1-YFP, caldendrin-YFP, CaM-YFP, or NCS1-YFP
were fixed in 4% paraformaldehyde for 15 min and washed twice
with PBS containing 20 mM glycine before permeabilization with
PBS-glycine containing 0.2% Triton X-100 (5 min incubation).
HEK-293T cells were treated for 1 h with PBS containing 1%
bovine serum albumin and labeled with the primary mouse anti-
RLuc antibody, and subsequently treated with: Cy3 anti-rabbit
[1/200; Jackson ImmunoResearch (red)] secondary antibodies
for 1 h. The YFP-fusion proteins were detected by YFP own
fluorescence. Samples were washed several times and mounted
with 30% Mowiol (Calbiochem). Samples were observed in a
Leica SP2 confocal microscope (Leica Microsystems). Scale bar:
10 µm for neurons and 20 µm for microglia cells.
Calcium Release
HEK-293T cells were co-transfected with the cDNA for the
indicated receptors and 0.75 µg of GCaMP6 calcium sensor
(Chen et al., 2013) using PEI protocol (Section “Cell Culture and
Transient Transfection”). Forty-eight hours after transfection,
cells (150,000 HEK-293T cells/well in 96-well black, clear bottom
microtiter plates) were incubated with Mg2+-free Locke’s buffer
pH 7.4 (154 mM NaCl, 5.6 mM KCl, 3.6 mM NaHCO3, 2.3 mM
CaCl2, 5.6 mM glucose, and 5 mM HEPES) supplemented with
10 µM glycine and receptor ligands were added just a few seconds
before readings. Fluorescence emission intensity of GCaMP6 was
recorded at 515 nm upon excitation at 488 nm on the EnSpire R©
Multimode Plate Reader for 335 s every 15 s and 100 flashes per
well.
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ERK Phosphorylation Assays
To determine ERK1/2 phosphorylation, HEK-293T cells
expressing GluN1 and GluN2B subunits and calneuron-1, CaM,
or NCS1, primary cultures of cortex or hippocampus microglia
cells or primary cultures of cortex or hippocampus neurons were
plated at a density of 40,000 cells/well in transparent Deltalab
96-well microplates and kept at the incubator between 1 and
7 days. Two to four hours before the experiment, the medium
was substituted by serum-starved DMEM medium. Then, cells
were pre-treated or not for 2 h or 7 days with α-synuclein, Tau,
and p-Tau proteins at 37◦C followed by treatment at 25◦C for
10 min with vehicle or antagonists (MK-801) in serum-starved
DMEM medium and stimulated for an additional 7 min with
NMDA. Cells were then washed twice with cold PBS before
addition of lysis buffer (20 min treatment). Ten microliters
of each supernatant were placed in white ProxiPlate 384-well
microplates and ERK 1/2 phosphorylation was determined
using AlphaScreen R©SureFire R© kit (PerkinElmer) following the
instructions of the supplier and using an EnSpire R© Multimode
Plate Reader (PerkinElmer, Waltham, MA, United States).
Proximity Ligation Assays (PLAs)
Interactions between NMDAR and calcium sensors were detected
using the Duolink II in situ PLA detection Kit (OLink; Bioscience,
Uppsala, Sweden) following the instructions of the supplier.
Primary cultures of neurons and microglia cells were grown
on glass coverslips and were fixed in 4% paraformaldehyde
for 15 min, washed with PBS containing 20 mM glycine to
quench the aldehyde groups, permeabilized with the same buffer
containing 0.05% Triton X-100 for 5 min, and successively
washed with PBS. After 1 h incubation at 37◦C with the blocking
solution in a pre-heated humidity chamber, primary cultures
were incubated overnight in the antibody diluent medium with
a mixture of equal amounts of rat monoclonal anti-NMDAR
antibody (1:200, Millipore) and a polyclonal rabbit anti-NCS1
antibody (1:100, Millipore) to detect NMDAR–NCS1 complexes,
or and the rabbit polyclonal anti-calneuron-1 antibody (1:100,
Abcam) to detect NMDAR-calneuron-1 complexes or and a
monoclonal rabbit anti-CaM antibody (1:50, Abcam) to detect
NMDAR–CaM complexes. Cells were processed using the PLA
probes detecting primary antibodies (Duolink II PLA probe plus
and Duolink II PLA probe minus) diluted in the antibody diluent
(1:5). Ligation and amplification were done as indicated by the
supplier and cells were mounted using the mounting medium
with Hoechst (1/200; Sigma). Samples were observed in a
Leica SP2 confocal microscope (Leica Microsystems, Mannheim,
Germany) equipped with an apochromatic 63× oil immersion
objective (N.A. 1.4), and a 405-nm and a 561-nm laser lines. For
each field of view, a stack of two channels (one per staining) and
four to eight Z stacks with a step size of 1 µm were acquired.
A quantification of cells containing one or more red spots versus
total cells (blue nucleus) and, in cells containing spots, the ratio
r (number of red spots/cell), were determined. One-way ANOVA
followed by Dunnett’s post hoc multiple comparison test was used
to compare the values (% of positive cells or r spots/cell) obtained
for each pair of receptors.
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FIGURE S1 | The N1 subunit of NMDAR receptor may interact with calmodulin,
calneuron-1 and NCS1. (A–D) BRET saturation experiments in HEK-293T cells
transfected with cDNAs for GluN1Rluc (0.3 µg), and increasing amounts of cDNA
for CaMYFP (0.05–0.4 µg) (A), calneuron-1YFP (0.05–1 µg) (B), NCS1YFP
(0.05–0.6 µg) (C), or caldendrin YFP (0.05–1 µg) (D). Values are the mean ± SEM
(n = 6).
FIGURE S2 | Proximity ligation assay (PLA) negative controls for PLAs in primary
cultures of neurons and microglia. PLAs were performed in cortical (A neurons,
C microglia) and hippocampal (B neurons, D microglia) cells incubated with the
anti-CaM antibody but omitting the anti-NMDAR antibody. Confocal microscopy
images are shown (superimposed sections) in which heteromers appear as red
clusters (in neurons or microglia). Scale bars = 10 µm (neurons) and 20 µm
(microglia). In all cases, cell nuclei were stained with Hoechst (blue).
FIGURE S3 | Tau, p-Tau, and α-synuclein dose–response curves in neuronal
primary cultures. (A–H) MAPK phosphorylation levels were analyzed in primary
cultures of cortical (A–D), or hippocampal neurons (E–H). Assays were performed
in cells treated with increasing concentrations of adenosine deaminase (ADA)
(5–500 µM). (A,E) Tau (0.05–5 µg/L) (B,F), p-Tau (0.05–5 µg/L) (C,G), or
α-synuclein (1 µM–100 µg/L) (D,H) for 2 h prior to 15 µM NMDA stimulation.
Values are the mean ± SEM (n = 6). Significant differences over NMDA treatment
(control condition) (∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.005) were calculated by
one-way ANOVA and Bonferroni post hoc test.
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FIGURE S4 | Chronic treatment with Tau, p-Tau, or α-synuclein inhibits
NMDAR-mediated signaling in primary cultures. (A–D) MAPK phosphorylation
levels were analyzed after stimulating primary cultures of cortical (A), or
hippocampal neurons (B), or of cortex (C), or hippocampal microglia (D).
Experiments were performed in cells transfected or not (black bars) with siRNA to
silence calneuron-1 (red bars), CaM (green bars), or NCS1 (blue bars) expression.
Assays were performed in cells treated with α-synuclein, Tau or p-Tau for 7 days
prior to 15 µM NMDA addition. Labels in X axis are equal in all bar graphs. Values
are the mean ± SEM (n = 10). Significant differences over non-treated cells
(∗∗p < 0.01, ∗∗∗p < 0.005) or over NMDA treatment (&p < 0.05, &&p < 0.01, and
&&&p < 0.001) were calculated by one-way ANOVA and Bonferroni post hoc test.
FIGURE S5 | Rescue of (endogenous) CaM silencing upon
transfection with the cDNA for CaM. (A,B) MAPK phosphorylation levels
were analyzed after stimulating primary cultures of cortical neurons
(A) or cortical microglia (B) with 15 µM NMDA. Experiments were performed
in cells transfected or not with siRNA to silence CaM; 24 h later, cells were
transfected with cDNA for CaM or with the (empty) pcDNA3.1 vector. Experiments
in untransfected (left), in siRNA (center), and in siRNA plus CaM (right)
cells were preformed simultaneously. Data are the mean ± SEM (n = 5). One-way
ANOVA followed by Bonferroni’s multiple comparison post hoc
test were used for statistics analysis (∗p < 0.05, ∗∗p < 0.01 versus NMDA
treatment).
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